Indaptus Therapeutics, Inc. is a clinical biotechnology company. The firm engages in the development of a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It created patented treatment methods and associated patented compositions for attenuation and killing of non-pathogenic, Gram-negative bacteria. The company was founded by Michael James Newman on February 24, 2021 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
5
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Indaptus Therapeutics Inc market cap is $433.16M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Indaptus Therapeutics Inc 52 week high is $5.96 as of November 21, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Indaptus Therapeutics Inc 52 week low is $0.92 as of November 21, 2026.
Indaptus Therapeutics Inc stock price today is $2.82.
Indaptus Therapeutics Inc stock price yesterday was $3.13.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Indaptus Therapeutics Inc's P/E ratio is -0.71.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Indaptus Therapeutics Inc P/B ratio is 36.3683.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Indaptus Therapeutics Inc 50-day moving average is $3.07.